PUBLICATION

CORRECTION: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease

Authors
Dong, X., Liao, Z., Gritsch, D., Hadzhiev, Y., Bai, Y., Locascio, J.J., Guennewig, B., Liu, G., Blauwendraat, C., Wang, T., Adler, C.H., Hedreen, J.C., Faull, R.L.M., Frosch, M.P., Nelson, P.T., Rizzu, P., Cooper, A.A., Heutink, P., Beach, T.G., Mattick, J.S., Müller, F., Scherzer, C.R.
ID
ZDB-PUB-220906-126
Date
2019
Source
Nature Neuroscience   22: 144-147 (Other)
Registered Authors
Keywords
none
MeSH Terms
none
PubMed
30482917 Full text @ Nat. Neurosci.
Abstract
In the version of this article initially published, the legends for Supplementary Figs. 4-8 and 10-14 contained errors. The Supplementary Figure legends have been corrected in the HTML and PDF versions of the article.
Errata / Notes
This article corrects ZDB-PUB-180919-5 .
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping